Table 2

Histological response to 4-HPR and placebo at 6 and 12 monthsa

Histological end pointProgressive diseaseNo changePartial responseComplete responseNo return after baselineTotal patients in studyTotal patients evaluable
6-mo4206633936
 4-HPR2134122220
 Placebo272511716
12-mo3174633330
 4-HPR2101121614
 Placebo173511716
  • a This Table does not reflect the crossover of two patients, which is reflected in Fig 2<$REFLINK> .